Fig. 5From: Coordinated activation of DNMT3a and TET2 in cancer stem cell-like cells initiates and sustains drug resistance in hepatocellular carcinomaUpregulation of DNMTs and TETs in HCC patients predicts unfavorable outcomes. a and b, the association of DNMTs and TETs expression with survival in liver cancer patients, which were generated in online tool GEPIA2 (c; http://gepia.cancer-pku.cn/)Back to article page